Monday, February 23, 2015 5:45:24 PM
GBHPF financials
Period Ending Sep 30, 2013 Sep 30, 2012 Sep 30, 2011 Oct 01/10
Total Revenue - - - -
Cost of Revenue 29 28 23 -
Gross Profit (29) (28) (23) -
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 35 64 105 -
Non-Recurring Items - - - -
Other - - - - -
Operating Income (64) (93) (128) -
Income From Continuing Operations
Add'l Income/Expense Items - (25) (252) -
Earnings Before Interest and Tax (64) (118) (380) -
Interest Expense - - -
Earnings Before Tax (64) (118) (380) -
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary- - - -
Net Income Cont. Operations (64) (118) (380) -
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (64) (118) (380) -
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (64) (118) (380)
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM